BioSpace News Archive

Business

HedgePath Pharmaceuticals Announces Name Change to INHIBITOR Therapeutics, Inc. and Ticker Symbol Change to “INTI” Effective August 20, 2019

HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI), today announced plans to change its name to INHIBITOR Therapeutics as well as a change to the ticker symbol for common and preferred stock to “INTI” from “HPPI.”

August 19, 2019

·

6 min read

Lilly Announces Webcast to Discuss World Conference on Lung Cancer Presentation

Eli Lilly and Company (NYSE: LLY) will conduct a webcast on Monday, September 9, 2019 to discuss data presented for its RET-Inhibitor, LOXO-292, at the 20th meeting of the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer in Barcelona, Spain

August 19, 2019

·

1 min read

MDA Selected to Build Robotic Interfaces for Canadarm3 on NASA-led Gateway

MDA, a Maxar company (NYSE: MAXR; TSX: MAXR), has been awarded two contracts from the Canadian Space Agency for work on Phase A of the Gateway External Robotic Interfaces project.

August 19, 2019

·

6 min read

Business

PRA Health Sciences Announces Strategic Alliance between Symphony Health and Close-Up International

PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, the company’s data solutions division, has expanded its global data services by entering into a strategic partnership with Close-Up International, a leading Latin American-based provider of medical prescription and sales audits.

August 19, 2019

·

4 min read

Pharm Country

Creative Peptides Provides Photo Cross Linkers for Custom Labeling in Peptide Modification

On August 15, 2019, the global leading peptide supplier Creative Peptides announces to release a product line of photo cross linkers for researchers who are engaged with custom labeling, peptide bioconjugation as well as peptide modification.

August 19, 2019

·

2 min read

FDA

Boston Scientific Announces FDA Approval Of ImageReady™ MRI For Vercise Gevia™ Deep Brain Stimulation System

Boston Scientific Corporation announced the US FDA approval of its ImageReady™ MRI labeling for the Vercise Gevia™ Deep Brain Stimulation System to be used in a full-body magnetic resonance imaging environment.

August 19, 2019

·

5 min read

Pharm Country

On Becoming a Physician: New Einstein Students Receive White Coats and Stethoscopes

Members of Albert Einstein College of Medicine’s class of 2023 received monogrammed white coats and stethoscopes last week in a ceremony marked with pride and reminders of responsibility as they embark on their lifelong journey of medical education.

August 19, 2019

·

6 min read

CStone submits an abstract on CS1001-201 trial to 2019 ASH Annual Meeting

CStone Pharmaceuticals announced that an abstract on the company’s CS1001-201 trial has been submitted to the upcoming 2019 American Society of Hematology Annual Meeting.

August 19, 2019

·

4 min read

BioMidwest

Nuvaira Announces Peer-Reviewed Publications of Targeted Lung Denervation Mechanisms of Action and Clinical Outcomes

Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announced today multiple peer-reviewed publications that provide further evidence of the safety, clinical effectiveness, and mechanisms of action of Targeted Lung Denervation (TLD) therapy in COPD.

August 19, 2019

·

2 min read

American Journal of Ophthalmology (AJO) Publishes Review Highlighting Lack of Treatments for Active Thyroid Eye Disease (TED)

A rigorous evaluation of the state of care for thyroid eye disease (TED) published in the American Journal of Ophthalmology (AJO) highlights the lack of current therapies to adequately treat the disease.

August 19, 2019

·

8 min read